CTOs on the Move

drchrono

www.drchrono.com

 
drchrono is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.drchrono.com
  • 1001 N. Rengstorff Avenue Suite 200
    Mountain View, CA USA 94043
  • Phone: 844.569.8628

Executives

Name Title Contact Details

Funding

drchrono raised $12M on 04/06/2017
drchrono raised $10M on 12/20/2018
drchrono raised $20M on 01/13/2020
drchrono raised $12M on 06/30/2021

Similar Companies

Family Counselling Centre

Family Counselling Centre is a Sarnia, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DataMetrix

DataMetrix is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Salt Lake City, UT. To find more information about DataMetrix, please visit www.data-metrix.com

Continucare Corporation

Continucare Corporation is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Continucare Corporation is based in Miami, FL. You can find more information on Continucare Corporation at www.continucare.com

Xtant Medical

Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.